No cases of Omicron variant in Egypt so far: Health Ministry    Egypt, UNICEF join hands to celebrate World Children's Day    AFG launches Sky Bridge complex in New Capital    Dahab Development opens reservation for ITC project at New Capital    Hope Givers Foundation honours Egyptologist Ali Abu Dashish    Egypt celebrates Day of Mediterranean    Travel bans due to Omicron "hammer blow" to South Africa's local economy recovery: official    EJB forms new board, pledges to support national economy    MICO entertainment platform enters Egyptian market    Art D'Egypte concludes 4th contemporary art exhibition "Forever is Now" at Giza Plateau    Austrian Cultural Forum in Cairo to launch exhibition highlighting Arab-Austrian ties    Egypt, Israel sign deal sign MoU to increase gas supplies, hydrogen transport    Egypt's stocks end week in green as benchmark EWX 30 surges 0.69%    Mortada Mansour sets road map for Zamalek, after normalization committee depart    I seek to secure stable financial sources to build strong judo team: Motei Fakhr El-Din    Egyptian karate players dazzle world in UAE    Orascom Construction joins consortium to develop Egypt's first green hydrogen production facility    Egypt's high committee to organise COP27 convenes to review preparations    98 potential candidates run for Libyan presidency    'Lake Victoria – Mediterranean' navigation corridor awaits feasibility studies, funds: official    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    Palestine's Foreign Ministry rejects UK's decision to designate Hamas as terror group    Egypt selected to host COP27 international climate conference in 2022    Number of British tourists to Egypt seen hitting 500,000 this winter – envoy    The unvaccinated prohibited from entry to Egypt state institutions starting December 1    Egypt, Greece ink deal for first subsea power link between Europe and Africa    SCOHRE sparks discussion on harm reduction, tobacco control    Egypt to receive first of six high-trains from Spain's Talgo in mid-November    Egypt's iron and steel exports jump 197% in 8 months    Ethiopia halts work at its embassy in Egypt for 'economic reasons'    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    Brazil calls up 8 EPL players for World Cup qualifying    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Sisi calls on House, Senate to commence second legislative sessions on 3, 5 October    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    Qa'a play showing at Lycee El Horreya Theatre, Alexandria is a must go    APO Group enters new exclusive agreement with Getty Images on African press releases and images    On International Museum Day, Egypt opens two new museums at Cairo Airport    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Coronavirus variants deadlier, more contagious; some may thwart vaccines
Published in Ahram Online on 21 - 03 - 2021

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus
Multiple variants can "escape" vaccines
Antibodies induced by the Moderna Inc and Pfizer Inc/BioNTech SE vaccines are dramatically less effective at neutralizing some of the most worrying coronavirus variants, a new study suggests. Researchers obtained blood samples from 99 individuals who had received one or two doses of either vaccine and tested their vaccine-induced antibodies against virus replicas engineered to mimic 10 globally circulating variants.
Five of the 10 variants were "highly resistant to neutralization," even when volunteers had received both doses of the vaccines, the researchers reported on Friday in Cell. All five highly resistant variants had mutations in the spike on the virus surface - known as K417N/T, E484K, and N501Y - that characterize a variant rampant in South Africa and two variants spreading rapidly in Brazil. In keeping with previous studies, the proportion of neutralizing antibodies dropped 5- to 6-fold against the variants discovered in Brazil.
Against the variant discovered in South Africa, neutralization fell 20- to 44-fold. A variant circulating now in New York has the E484K mutation. "While studies of the New York variant are ongoing, our findings suggest that similar variants harboring E484K may be harder for vaccine-induced antibodies to neutralize," said study leader Alejandro Balazs of Harvard University and the Massachusetts General Hospital. "Despite our results," he added, "it's important to consider that vaccines raise other kinds of immune responses which could protect against developing severe disease."
Variant identified in UK is deadlier
The coronavirus variant first identified in the UK, known as B.1.1.7, is deadlier than other variants circulating there, a new study appears to confirm.

Researchers analyzed data on 184,786 people in England diagnosed with COVID-19 between mid-November and mid-January, including 867 who died. For every three people who died within four weeks after being infected with another variant, roughly five died after becoming infected with B.1.1.7, according to a paper posted on medRxiv ahead of peer review. Overall, the risk of death with B.1.1.7 was 67% higher than the risk with other variants in England, the authors said.

As with earlier variants, patients' risk of death increased with age, male gender, and pre-existing medical conditions. B.1.1.7 is now prevalent across Europe and predicted to become prevalent in the United States. "Crucially," the researchers wrote, "emerging data suggest that the currently approved vaccines for SARS-CoV-2 are effective against the B.1.1.7."
Variant identified in Brazil is doubly infectious
Between November and January in Manaus, Brazil, the frequency of COVID-19 cases involving the P.1 coronavirus variant increased from non-existent to 73%, and the number of infections there quadrupled compared to what the city experienced in the first wave of the pandemic, according to a report posted on medRxiv ahead of peer review.
The greater infectiousness of the P.1 variant likely contributed to that, the report suggests. Based on national health surveillance data, the authors estimate that the P.1 variant is roughly 2.5 times more transmissible than previous variants circulating in Manaus.
The spread of P.1 occurred despite the fact that 68% of the city's population had already been infected by the original strain of the coronavirus, the researchers noted. In their analysis, the risk of reinfection with P.1 was low. The ability of the variant to cause severe disease, or its pathogenicity, is still unclear. "The P.1 variant has already been detected in at least 25 countries," the authors said. "This calls for urgent ... studies of the P.1 variant, since greater transmissibility and pathogenicity can drive even well-prepared health systems to collapse."


Clic here to read the story from its source.